Edward Miller
Oral & Maxillofacial Surgery · New York, NYNPI 1649327644
Payments from drug & device makers
Across 27 payments — averaging $43.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nobel Biocare USA$474
- Geistlich Pharma, North America, Inc.$294
- Zimvie Inc.$211
- Straumann USA LLC$121
- Inspire Medical Systems, Inc.$34
- Biohorizons Implant Systems Inc.$19
- plus $16 from 1 others
What the payments were for
- Food & beverage$1,12096%
- Education$504%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nobel Biocare USA | 8 | $474 |
| Geistlich Pharma, North America, Inc. | 1 | $294 |
| Zimvie Inc. | 11 | $211 |
| Straumann USA LLC | 4 | $121 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| Biohorizons Implant Systems Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Geistlich Bio Gide$294
- NOBELPARALLEL$107
- NOBELACTIVE$107
How this compares
$1,170 in reported general payments places this provider in the 65th percentile of 605 oral & maxillofacial surgery providers in New York.
See all oral & maxillofacial surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 117 | $252 |
| CefuroximeCefuroxime Axetil | 16 | $155 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $68 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 22 | $57 |
| Ibuprofen | 19 | $53 |
| Azithromycin | 17 | $29 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $28 |
| Tramadol Hcl | 28 | $24 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in New York
- Daniel BuchbinderNew York$422K
- Vasiliki KarlisNew York$201K
- Yan TrokelNew York$86K
- David HirschNew York$46K
- Michael TurnerNew York$38K
- Alex GreenbergNew York$31K
- Gwendolyn ReeveNew York$16K
- Andrea TorroniNew York$16K
- Brian SchmidtNew York$13K
- Artem KrutyanskyNew York$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.